Edap TMS SA (EDAP)

3.15
0.02 0.63
NASDAQ : Health Care
Prev Close 3.17
Open 3.15
Day Low/High 3.07 / 3.21
52 Wk Low/High 2.76 / 6.57
Volume 34.04K
Avg Volume 63.70K
Exchange NASDAQ
Shares Outstanding 28.73M
Market Cap 91.07M
EPS -0.10
P/E Ratio 18.65
Div & Yield N.A. (N.A)

Latest News

EDAP To Report Third Quarter 2016 Financial Results On November 17, 2016

EDAP To Report Third Quarter 2016 Financial Results On November 17, 2016

Conference Call and Webcast Scheduled for 8:30 a.m. ET

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMS, ASUR, EDAP Downgrades: ACSF, AG, ASYS, INFO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

EDAP To Report Second Quarter 2016 Financial Results On August 25, 2016

EDAP To Report Second Quarter 2016 Financial Results On August 25, 2016

Conference Call and Webcast Scheduled for 8:30 a.m. ET

EDAP Announces First HIFU Treatments Performed In New England

EDAP Announces First HIFU Treatments Performed In New England

Ablatherm Robotic HIFU Deployed by HIFU USA; Initial Treatments Performed in New York by Dr. Ron Israeli and in New England by Drs. Clifford Gluck and James Lin

EDAP To Report First Quarter 2016 Results On May 18, 2016

EDAP To Report First Quarter 2016 Results On May 18, 2016

Conference Call and Webcast Scheduled for 8:30 a.m. ET

EDAP's Ablatherm® Robotic HIFU Deployed By HIFU Solution

EDAP's Ablatherm® Robotic HIFU Deployed By HIFU Solution

Leading HIFU Mobilizer Begins Operation on Ablatherm® Robotic HIFU Following First Quarter 2016 Purchase

EDAP To Report Fourth Quarter And Full Year 2015 Results On April 4, 2016

EDAP To Report Fourth Quarter And Full Year 2015 Results On April 4, 2016

Conference Call and Webcast Scheduled for 8:30 a.m. ET

First Patients Treated With EDAP's Ablatherm® Robotic HIFU In New York

First Patients Treated With EDAP's Ablatherm® Robotic HIFU In New York

Procedures Performed at Gramercy Surgery Center by Dr. Ivan Grunberger, Assisted by Dr. Judd Boczko

EDAP Announces Results Of World's First Focal HIFU Trial

EDAP Announces Results Of World's First Focal HIFU Trial

100% Cancer Specific Survival, 94% Continence Preservation and 80% Potency Preservation